Answering this question will have an important impact on reducing the well-documented morbidity and mortality, making the operation simpler and cost-effective.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:This article consists of a subject review supported by a short-term pilot study which was conducted prospectively to shed light into the controversial question regarding the necessity of having the defibrillation threshold measured at the time of the implantable cardioverter defibrillator implantation.
📊
Key Findings & Data:This article consists of a subject review supported by a short-term pilot study which was conducted prospectively to shed light into the controversial question regarding the necessity of having the defibrillation threshold measured at the time of the implantable cardioverter defibrillator implantation.
💡
Conclusion & Impact:Answering this question will have an important impact on reducing the well-documented morbidity and mortality, making the operation simpler and cost-effective.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
This article consists of a subject review supported by a short-term pilot study which was conducted prospectively to shed light into the controversial question regarding the necessity of having the defibrillation threshold measured at the time of the implantable cardioverter defibrillator implantation. Answering this question will have an important impact on reducing the well-documented morbidity and mortality, making the operation simpler and cost-effective.
Özet
Bu makale implantabl kardiyoverter defibrilatör takılması sırasında defibrilasyon eşiğinin ölçülmesi gerekliliğine ilişkin tartışmalı bir soruya ışık tutmak üzere, ileriye dönük olarak yürütülen kısa süreli önemli bir çalışma ile desteklenen bir konu incelemesinden oluşmuştur. Bu sorunun yanıtlanması, işlemi daha kolay ve maliyet etkin bir hale getirerek, iyi düzeyde belgelenmiş morbidite ve mortalitenin azaltılması üzerinde önemli bir etkisi olacaktır.
🔖
Cite This Article
FOMENKO, A., ALİ, I. (2022). İnternal defibrilatör takılması sırasında defibrilasyon eşik testinden kaçınılması: Güvenli mi?. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 20 - Sayı: 2, 406–409. https://ajindex.com/articles/424704
Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90
Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:746-837
Zipes DP, Roberts D. Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators. Circulation 1995;92:59-65
Birnie D, Tung S, Simpson C, Crystal E, Exner D, Ayala Paredes FA, et al. Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm 2008;5:387-90
Duray GZ, Hohnloser SH. Defibrillation testing: the need for a definitive trial. J Cardiovasc Electrophysiol 2010;21:183-5
Swerdlow CD, Russo AM, Degroot PJ. The dilemma of ICD implant testing. Pacing Clin Electrophysiol 2007;30:675-700
Russo AM, Sauer W, Gerstenfeld EP, Hsia HH, Lin D, Cooper JM, et al. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverterdefibrillator insertion? Heart Rhythm 2005;2:456-61
Pires LA, Johnson KM. Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough? J Cardiovasc Electrophysiol 2006;17:140-5
Blatt JA, Poole JE, Johnson GW, Callans DJ, Raitt MH, Reddy RK, et al. No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2008;52:551-6
Joglar JA, Kessler DJ, Welch PJ, Keffer JH, Jessen ME, Hamdan MH, et al. Effects of repeated electrical defibrillations on cardiac troponin I levels. Am J Cardiol 1999;83:270-2, A6
Frame R, Brodman R, Furman S, Kim SG, Roth J, Ferrick K, et al. Clinical evaluation of the safety of repetitive intraoperative defibril